Log in

Start Your Membership Now

Ensuring Leadership Continuity—The Coleman Health Services Case Study is starting in
About
Contact

Become A Member
Log in

Markets
Services
Customers

Market Intel Homepage

Search Library

Publications
Markets
Topics
Executive Institutes
Professional Development Programs
The OPEN MINDS Leadership & Management Certificate The OPEN MINDS CFO Consortium
Tools
Assessments
View By Topic View By Partner

Health Plan Trends

Population Health

The OPEN MINDS CFO Consortium

The OPEN MINDS Leadership & Management Certificate

Alera Health

ContinuumCloud

Otsuka

View By Topic View By Partner

Acute Care

AI In Process/Workflow Improvement

Clinically Integrated Systems Of Care

Employee Recruitment & Retention

Innovations in Autism & Behavioral Healthcare

Metrics-Based Mgmt//Data-Driven Decision Making

Performance Management

Transformational Leadership For Non-Profits

Workforce Optimization

AI/Advanced Technologies To Improve Outcomes

Automation Of Services/Processes

Concurrent Documentation

Hybrid/Virtual Care

Long-Term Services & Supports

Operational Excellence

Quality Of Care

Transforming Data To Action

AI in Analytics

CCBHCs

Crisis Management & Technology

Innovation

Medication-Assisted Treatment

Patient/Consumer Engagement

Technology Strategy

Trauma Informed Approaches

ContinuumCloud

Netsmart

Axiom EHR

CCNY

Genoa Healthcare

iCareManager

Mend

ServiceWorks

Vivant Behavioral Healthcare

Core Solutions

5e Analytics

Cantata Health Solutions

Eleos

Grafton Integrated Health Network

Insperity

NextGen Healthcare

Streamline Healthcare Solutions

Qualifacts

Altruix

Carelon

Five Points Technology Group

Hartman Executive Advisors

Juno Health

Relias

The BI Collaborative

Market Watch | January 12, 2017

Minerva Neurosciences Names New Chief Medical Officer

Minerva Neurosciences (Minerva) has named Michael Davidson, M.D. as its newest Chief Medical Officer. With significant experience in drug treatment research and development for diseases of the central nervous system, Dr. Davidson takes over strategic development and clinical advancement of Minerva's products.

Minerva Neurosciences is a clinical-stage biopharmaceutical company focused on therapy development for central nervous system disorders including schizophrenia, insomnia, major depressive disorder, and Parkinson's disease.

This was reported by GlobeNewswire on December 20, 2016.

Contact Information: Minerva Neurosciences, Inc.; 1601 Trapelo Road, Suite 284, Waltham, MA 02451; Email: info@minervaneurosciences.com; Website: www.minervaneurosciences . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
Log In
If you are already a member, log in to your account to access this resource and more.

Become A Free Member
You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Tagged As: